Relation of ACE2 with co-morbidity factors in SARS-CoV-2 pathogenicity

Comp Clin Path. 2023;32(2):179-189. doi: 10.1007/s00580-023-03434-9. Epub 2023 Jan 17.

Abstract

In the last 3 years of the pandemic situation, SARS-CoV-2 caused a significant number of deaths. Infection rates for symptomatic and asymptomatic patients are higher than that for death. Eventually, researchers explored that the major deaths are attributed to several comorbidity factors. The confounding factors and gender-associated infection/death rate are observed globally. This suggests that SARS-CoV-2 selects the human system recognizing the internal comorbid environment. This article explored the influences of hypertension, diabetes, cardiovascular, and renovascular disorders in COVID-19 severity and mortality. Brief mechanistic layouts have been presented here, indicating some of the comorbidity as the critical determinant in the COVID-19 pathogenesis and related mortality.

Keywords: Comorbidity factors; Hypertension and diabetes; Infection and mortality; Peripheral vascular disease; SARS-CoV-2.

Publication types

  • Review